News and Stories

A symposium co-hosted by HBHI and the Hopkins Economics of Alzheimer's Disease and Services Center covers the ramifications of the approval of controversial Alzheimer's Disease drug Aduhelm for patients enrolled in approved clinical trials.

How people have responded to the COVID-19 pandemic provides insight into the ways that people make decisions, alter their behavior, and respond to other major threats.

Get to know Beth McGinty

Ge Bai, PhD, led a new study in Medical Care Research and Review recommending that policy makers should consider improving transparency of the commission made by insurance agents and brokers to help facilitate employers making efficient broker contracting and plan purchasing decisions.